1. Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F] fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate pancer: multicenter Phase IIb clinical trial. (5th December 2016) Authors: Suzuki, Hiroyoshi; Inoue, Yusuke; Fujimoto, Hiroyuki; Yonese, Junji; Tanabe, Kazunari; Fukasawa, Satoshi; Inoue, Tomio; Saito, Shiro; Ueno, Munehisa; Otaka, Akiharu Journal: Japanese journal of clinical oncology Issue: Volume 47:Number 3(2017) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗